First published online January 17, 2007
Journal of Experimental Biology 210, 438-446 (2007)
Published by The Company of Biologists 2007
doi: 10.1242/jeb.02680
Cu2+ and acute thermal stress induce protective events via the p38-MAPK signalling pathway in the perfused Rana ridibunda heart
Catherine Gaitanaki,
Maria Pliatska,
Konstantina Stathopoulou and
Isidoros Beis*
Department of Animal and Human Physiology, School of Biology, Faculty
of Sciences, University of Athens, Panepistimioupolis, Athens 157 84,
Greece

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 1. Perfusion protocols. For further details, see Materials and methods; for
abbreviations, see List of abbreviations.
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2. Phosphorylation of p38-MAPK and Hsp-27 by CuCl2. (A,C) Protein
(A, 50 µg or C, 100 µg) from Rana ridibunda hearts perfused in
the absence (Con) or presence of increasing concentrations of CuCl2
(50500 µmol l1) for 15 min was analysed by
immunoblotting with anti-p38-MAPK (Ai) and anti-Hsp27 (C) phosphospecific
antibodies. As a positive control, extracts from hearts perfused with 50
µmol l1 H2O2 for 2 min were
included. Identical samples were assayed with an anti-actin antibody as a
control for protein loading (Aii). (B,D) Densitometric analysis of
phospho-p38-MAPK (B) and phospho-Hsp27 (D) bands, by laser scanning. Results
are means ± s.e.m. for three independent experiments.
*P<0.05, **P<0.01,
P<0.001 vs control value.
|
|

View larger version (6K):
[in this window]
[in a new window]
|
Fig. 3. Effect of the selective inhibitor SB203580 on the p38-MAPK and Hsp27
phosphorylation induced by CuCl2. Protein (50 µg, top and
bottom, and 100 µg, middle) from hearts perfused without or with 500
µmol l1 CuCl2 for 15 min in the absence or
presence of 1 µmol l1 SB203580 was analysed by
immunoblotting with phosphospecific anti-p38-MAPK (top), phosphospecific
anti-Hsp27 (middle) or anti-actin (bottom) antibodies. Western blots shown are
representative of four independent experiments performed with similar
results.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4. Time course of p38-MAPK phosphorylation in the amphibian heart, in response
to reperfusion after CuCl2 treatment. (A) Phospho-p38-MAPK was
detected in extracts (50 µg protein) from control hearts (Con), hearts
perfused with 500 µmol l1 CuCl2 for 15 min or
hearts perfused for the indicated times with normal bicarbonate-buffered
saline following the 15 min perfusion with 500 µmol l1
CuCl2. As a positive control, extract from hearts perfused with 50
µmol l1 H2O2 for 2 min was used
(Ai). Equal loading was assessed, as previously, using an actin antibody
(Aii). (B) Densitometric analysis of phospho-p38-MAPK bands by laser scanning.
Results are means ± s.e.m. for three independent experiments. Re,
reperfusion. *P<0.05, **P<0.01,
P<0.001 vs control value.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5. Phosphorylation of p38-MAPK and Hsp27 by the combined effects of
CuCl2 and hyperthermia (42°C). (A,C) Phosphorylated p38-MAPK
(A,top) and Hsp27 (C) levels were detected in extracts (50 and 100 µg of
protein, respectively) from Rana ridibunda hearts perfused for 15 min
with normal bicarbonate-buffered saline maintained at 25°C (Con) or at
42°C, either in the absence or presence of 500 µmol
l1 CuCl2. As a positive control, extracts from
hearts perfused with 50 µmol l1
H2O2 for 2 min were included. Identical samples were
analysed using an actin antibody as a control for protein loading (A,bottom).
(B,D) Densitometric analysis of phospho-p38-MAPK (B) and phospho-Hsp27 (D)
bands by laser scanning. Results are means ± s.e.m. for three
independent experiments. *P<0.05,
**P<0.01, P<0.001
vs control value.
|
|

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 6. Effect of L-ascorbic acid on the CuCl2induced p38-MAPK
phosphorylation. (A) Protein (50 µg) from Rana ridibunda hearts
perfused without (Con) or with 100 µmol l1 L-ascorbic
acid (ASC) for 15 min, in the presence or absence of 500 µmol
l1 CuCl2, was analysed by immunoblotting with a
phosphospecific anti-p38-MAPK antibody (top). Equal loading was verified by
blotting identical samples with an anti-actin-specific antibody (bottom). (B)
Densitometric analysis of phospho-p38-MAPK bands by laser scanning. Results
are means ± s.e.m. for three independent experiments performed with
similar findings. *P<0.05,
P<0.001 vs control value.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 7. Effect of different antioxidants on the p38-MAPK phosphorylation induced by
CuCl2 in the absence or presence of hyperthermia (42°C).
Phospho-p38-MAPK was detected in extracts (50 µg protein) from control
hearts (Con), hearts perfused for 15 min with 30 U ml1 SOD
alone or with 500 µmol l1 CuCl2, either in the
absence or the presence of 30 U ml1 SOD, 150 U
ml1 CAT or the combination of SOD+CAT, at 25°C. In
addition, hearts were perfused for 15 min with 500 µmol
l1 CuCl2 and identical combinations of
antioxidant agents but at 42°C (Ai). Actin protein levels of identical
samples were detected so as to confirm equal protein loading (Aii).
Densitometric analysis of phospho-p38-MAPK bands by laser scanning was
performed (B). Results are means ± s.e.m. for three independent
experiments. *P<0.05, **P<0.01,
P<0.001 vs control value.
|
|

View larger version (6K):
[in this window]
[in a new window]
|
Fig. 8. Absence of caspase-3 activation by CuCl2, at 25°C or at
42°C, in the absence or presence of CAT and SOD. Immunoblot analysis using
a specific antibody that recognizes both the inactive full-length
pro-caspase-3 and the fragmented active form of the protein led to the
detection of only pro-caspase-3 in samples (100 µg protein) from hearts
perfused without or with 500 µmol l1 CuCl2 for
15 min, either in the absence or the presence of 30 U ml1
SOD, 150 U ml1 CAT or the combination of SOD+CAT, at
25°C or at 42°C. Western blot shown is representative of three
independent experiments performed with similar results. The positions of
marker proteins are shown on the left.
|
|
© The Company of Biologists Ltd 2007